Histogenesis and histopathological characteristics of Sertoli-Leydig cell tumors

CME Journal of Gynecologic Oncology

Volumn 7, Issue 2, 2002, Pages 114-120

  Nouriani, Mory ^a   Felix, Juan C ^a   Dubeau, Louis ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Histogenesis; Histology; Inhibin; Sertoli Leydig cell tumors

Indexed keywords

ANDROBLASTOMA; CANCER CLASSIFICATION; CLINICAL EXAMINATION; DIFFERENTIAL DIAGNOSIS; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; OVARY TUMOR; REVIEW;

EID: 0036662832     PISSN: 12199087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Novak ER, Long JH. Arrhenoblastoma of the ovary. A review of the ovarian tumor registry. Am J Obstet Gynecol 1965; 92:1082.
2. O'Hearn TM, Neubecker RD. Arrhenoblastoma. Obstet Gynecol 1962; 19:758.
3. Serov SF, Scully RE, Sobin LH. Histological typing of ovarian tumors. International Classification of Tumors. Geneva: World Health Organization, 1973.
4. Tavassoli FA, Norris HJ. Sertoli tumors of the ovary. A clinicopathologic study of 28 cases with ultrastructural observations. Cancer 1980; 46:2281-97.
5. Rodriguez M, Dubeau L. Ovarian tumor development: Insights from ovarian embryogenesis. Eur J Gynaecol Oncol 2001; 22:175-83.
6. Karl J, Capel B. Sertoli cells of the mouse testis originate from the coelomic epithelium. Dev Biol 1998; 203:323-33.
7. Merchant-Larios H. The onset of testicular differentiation in the rat: An ultrastructural study. Am J Anat 1976; 145:319-29.
8. Mackay S, Bashir AA, Birnie DH. Primordial germ cells and gonadal development in the golden hamster. J Anat 1989; 164:155-63.
9. Mackay S. Gonadal development in mammals at the cellular and molecular levels. Int Rev Cytol 2000; 200:47-99.
10. McClaren A. Relation of germ cell sex to gonadal differentiation. In Halvorason HO, Monroy A, editors. The Origin and Evolution of Sex. New York: Alan R. Liss, 1985, p. 289-300.
11. Pelliniemi LJ. Ultrastructure of the early ovary and testis in pig embryos. Am J Anat 1975; 144:89-111.
12. Wartenberg H. Origin of gonadal blastemal cells in mammalian gonadogenesis. Arch Anat Microsc Morphol Exp 1985; 74:60-63.
13. Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, et al. Anti-Mullerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol 2000; 31:1202-08.
14. Dutertre M, Rey R, Porteu A, Josso N, Picard JY. A mouse Sertoli cell line expressing anti-Mullerian hormone and its type II receptor. Mol Cell Endocrinol 1997; 136:57-65.
15. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL, Skakkebaek NE. Expression of anti-Mullerian hormone during normal and pathological gonadal development: Association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999; 84:3836-44.
16. Jarred RA, Cancilla B, Richards M, Groome NP, McNatty KP, Risbridger GP. Differential localization of inhibin subunit proteins in the ovine testis during fetal gonadal development. Endocrinology 1999; 140:979-86.
17. Devouassoux-Shisheboran M, Silver SA, Tavassoli FA. Wolffian adnexal tumor, socalled female adnexal tumor of probable Wolffian origin (FATWO): Immunohistochemical evidence in support of a Wolffian origin. Hum Pathol 1999; 30:856-63.
18. Hittmair A, Zelger BG, Obrist P, Dirnhofer S. Ovarian Sertoli-Leydig cell tumor: A SRY gene-independent pathway of pseudomale gonadal differentiation. Hum Pathol 1997; 28:1206-10.
19. Nordqvist K. Sex differentiation - Gonadogenesis and novel genes. Int J Dev Biol 1995; 39:727-36.
20. Klonisch T, Hombach-Klonisch S, Buchmann J, Fischer B, Bergmann M, Steger K. Relaxin-like factor expression in a human ovarian Sertoli-Leydig cell tumor. Fertil Steril 1999; 72:546-48.
21. Cao QJ, Jones JG, Li M. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol 2001; 20:346-52.
22. Merchant-Larios H, Moreno-Mendoza N. Mesonephric stromal cells differentiate into Leydig cells in the mouse fetal testis. Exp Cell Res 1998; 244:230-38.
23. Buehr M, Gu S, McLaren A. Mesonephric contribution to testis differentiation in the fetal mouse. Development 1993; 117:273-81.
24. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer, Cell 2000; 100:57-70.
25. Dowdy SC, O'Kane DJ, Keeney GL, Boyd J, Podratz KC. Telomerase activity in sex cord-stromal tumors of the ovary. Gynecol Oncol 2001; 82:257-60.
26. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-15.
27. Takekawa Y, Kimura M, Sakakibara M, Yoshii R, Ato M, Nemoto N, et al. Immunohistochemical study of Sertoli-stromal cell tumor; comparison between the tumor arising from the gonad of a testicular feminization syndrome bearing patient and from ovaries of non-bearing patients. Rinsho Byori. Jpn J Clin Pathol 1999; 47:1070-74.
28. Manegold E, Tietze L, Gunther K, Fleischer A, Amo-Takyi BK, Schroder W, et al. Trisomy 8 as sole karyotypic aberration in an ovarian metastasizing Sertoli-Leydig cell tumor. Hum Pathol 2001; 32:559-62.
29. Taruscio D, Carcangiu ML, Ward DC. Detection of trisomy 12 on ovarian sex cord stromal tumors by fluorescence in situ hybridization. Diagn Mol Pathol 1993; 2:94-98.
30. Hitosugi M, Matsuoka Y, Irimajiri S, Fukuda J. Sertoli-Leydig cell tumour complicated by X chromosomal mosaicism. Clin Endocrinol (Oxf) 1997; 47:619-22.
31. Prat J, Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle: A clinicopathologic analysis of twelve cases. Cancer 1982; 50:2465-75.
32. Young RH, Scully RE. Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 1985; 9:543-69.
33. Arai N, Misugi K, Kamiya T, Shima S. An ovarian Sertoli-Leydig cell tumor with heterologous mucinous gland and NSE-immunoreactive-cell. Arch Gynecol Obstet 1988; 243:55-60.
34. Young RH, Prat J, Scully RE. Ovarian Sertoli-Leydig cell tumors with heterologous elements. I. Gastrointestinal epithelium and carcinoid: A clinicopathologic analysis of thirty-six cases. Cancer 1982; 50:2448-56.
35. Guerard MJ, Ferenczy A, Arguelles MA, Ovarian Sertoli-Leydig cell tumor with rhabdomyosarcoma: An ultrastructural study. Ultrastruct Pathol 1982; 3:347-58.
36. Gilcrease MZ, Delgado R, Albores-Saavedra J. Testicular Sertoli cell tumor with a heterologous sarcomatous component: Immunohistochemical assessment of Sertoli cell differentiation. Arch Pathol Lab Med 1998; 122:907-11.
37. Stewart CJ, Jeffers MD, Kennedy A. Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Histopathology 1997; 31:67-74.
38. Kommoss F, Oliva E, Bhan AK, Young RH, Scully RE. Inhibin expression in ovarian tumors and tumor-like lesions: An immunohistochemical study. Mod. Pathol. 1998; 11:656-64.
39. Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF, Woodcock AS. Sertoli-Leydig cell tumors: A clinicopathologic study of 34 cases. Cancer 1981; 48:187-97.
40. Zaloudek C, Norris HJ. Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 1984; 8:405-18.
41. Young RH, Scully RE. Ovarian Sertoli cell tumors: A report of 10 cases. Int J Gynecol Pathol 1984; 2:349-63.
42. Talerman A. Ovarian Sertoli-Leydig cell tumor (androblastoma) with retiform pattern. A clinicopathologic study. Cancer 1987; 60:3056-64.
43. Osborne RH, Yannone ME. Plasma androgens in the normal and androgenic female. Obstet Gynecol Surv 1971; 26:195.
44. Prunty FT. Hirsutism, virilism and apparent virilism and their gonadal relationship. J Endocrinol 1967; 38:85-103.
45. Teilum G. Homologous ovarian and testicular tumors. III. Estrogen producing Sertoli cell tumors (androblastoma tubulare lipoids) of the human testis and ovary. J Clin Endocrinol 1949; 9:301.
46. Aguirre P, Scully RE. Testosterone-secreting adrenal ganglioneuroma containing Leydig cells. Am J Surg Pathol 1983; 7:699-705.
47. Chumas JC, Rosenwaks Z, Mann WJ, Finkel G, Pastore J. Sertoli-Leydig cell tumor of the ovary producing alpha-fetoprotein. Int J Gynecol Pathol 1984; 3:213-19.
48. Gagnon S, Tetu B, Silva EG, McCaughey WT. Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: An immunohistochemical study of eight cases. Mod Pathol 1989; 2:63-67.
49. Young RH, Perez-Atayde AR, Scully RE. Ovarian Sertoli-Leydig cell tumor with retiform and heterologous components. Report of a case with hepatocytic differentiation and elevated serum alpha-fetoprotein. Am J Surg Pathol 1984; 8:709-18.
50. Young RH, Scully RE. Well-differentiated ovarian Sertoli-Leydig cell tumors: A clinicopathological analysis of 23 cases. Int J Gynecol Pathol 1984; 3:277-90.
51. Slayton RE. Management of germ cell and stromal tumors of the ovary. Semin Oncol 1984; 11:299-313.
52. Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976; 125:402-11.
53. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB, Wharton JT. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 1987; 70:765-69.